Veterinary Medicines

BIMACURE 500 MG INTRAUTERINE SUSPENSION FOR CATTLE

Authorised
  • Cefapirin benzathine
Download as PDF

Product identification

Medicine name:
BIMACURE 500 MG INTRAUTERINE SUSPENSION FOR CATTLE
Bimacure 500 mg intrauterīnā suspensija liellopiem
Active substance:
  • Cefapirin benzathine
Target species:
  • Cattle
Route of administration:
  • Intrauterine use

Product details

Active substance and strength:
  • Cefapirin benzathine
    640.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intrauterine suspension
Withdrawal period by route of administration:
  • Intrauterine use
    • Cattle
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG51AA05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:
  • Pack containing 10 syringes (low linear density polyethylene syringe barrel with low density polyethylene plunger and cap containing 19 g of oily suspension), 10 intrauterine catheters and 10 disposable gloves.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bimeda Animal Health Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dopharma France S.A.S.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/DCP/22/0029
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0419/001
Concerned member states:
  • Austria
  • Estonia
  • Germany
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Poland
  • Spain

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 4/11/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."